A Multiple-center, Self-controlled Open Study to Evaluate Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer.
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2013
At a glance
- Drugs Teprenone (Primary)
- Indications Gastric ulcer; Gastritis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2012 Planned end date changed from 1 Nov 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 19 Sep 2012 Planned End Date changed from 1 Aug 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.